Venous [bpoc]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Plasma [bdsu]
Levels [qlco]
bosentan [orch, phsu]
treatment [ftcn]
pulmonary [bpoc]
Arterial [bpoc]
Hypertension [dsyn]
Objective [inpr]
bosentan [orch, phsu]
Endothelium [tisu]
ETA Receptor Antagonist [phsu]
ETB [gngm]
effective [qlco]
therapy [ftcn]
Idiopathic Pulmonary Arterial Hypertension [dsyn]
Pulmonary arterial hypertension [dsyn]
Connective tissue disease [dsyn]
Study [mnob]
Evaluate [ftcn]
Behavior [inbe]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Venous [bpoc]
Plasma [bdsu]
Dual [inpr]
Endothelium [tisu]
receptor [aapp, rcpt]
Blockade [ftcn]
influential [idcn]
baseline [bodm]
Venous [bpoc]
Plasma [bdsu]
Efficacy [qlco]
bosentan [orch, phsu]
setting [ftcn]
Patients [podg]
twenty [orch, phsu]
Five [qnco]
Patients [podg]
Pulmonary arterial hypertension [dsyn]
Idiopathic [ftcn]
Connective tissue disease [dsyn]
Functional [ftcn]
Class III [inpr]
Ii [aapp]
included [ftcn]
Study [mnob]
Initial [tmco]
Evaluation [ftcn]
Patients [podg]
Class [inpr]
minute [tmco]
Walking [dora]
Test [lbpr]
Brain natriuretic peptide level [lbpr]
Venous [bpoc]
Plasma [bdsu]
Assessed [acty]
baseline [bodm]
bosentan [orch, phsu]
therapy [ftcn]
Evaluate [ftcn]
Levels [qlco]
Response [orga]
bosentan [orch, phsu]
Whole [qnco]
Stratified [qlco]
Plasma [bdsu]
baseline [bodm]
Value [qnco]
Plasma [bdsu]
GR [aapp, rcpt]
pg/mL [qnco]
GR [aapp, rcpt]
pg/mL [qnco]
Study Population [popg]
included [ftcn]
Patients [podg]
Moderate [qlco]
Severe [qlco]
Pulmonary arterial hypertension [dsyn]
treatment [ftcn]
Observed [ftcn]
minute [tmco]
Walking distance [fndg]
Test [lbpr]
M NOS [aapp, imft]
M NOS [aapp, imft]
P NOS [aapp, imft]
Improvement [cnce]
Class [inpr]
P NOS [aapp, imft]
Decrease [qlco]
Natriuretic Peptide, Brain [aapp, horm, phsu]
pg/mL [qnco]
pg/mL [qnco]
P NOS [aapp, imft]
trend [tmco]
Plasma [bdsu]
pg/mL [qnco]
pg/mL [qnco]
P NOS [aapp, imft]
Improvement [cnce]
Effort [orgf]
Tolerance [fndg]
Delta [inpr]
Distance [qnco]
Correlated [qlco]
Modification [ftcn]
Delta [inpr]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Delta [inpr]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Plasma [bdsu]
Correlation [qlco]
Delta [inpr]
Delta [inpr]
Natriuretic Peptide, Brain [aapp, horm, phsu]
R- [spco]
P NOS [aapp, imft]
Subpopulation [popg]
GR [aapp, rcpt]
Patients [podg]
Old [tmco]
GR [aapp, rcpt]
GR [aapp, rcpt]
P NOS [aapp, imft]
Effort [orgf]
Capacity [qnco]
minute [tmco]
Walking distance [fndg]
Test [lbpr]
M NOS [aapp, imft]
GR [aapp, rcpt]
M NOS [aapp, imft]
P NOS [aapp, imft]
trend [tmco]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Values [qlco]
GR [aapp, rcpt]
pg/mL [qnco]
GR [aapp, rcpt]
pg/mL [qnco]
P NOS [aapp, imft]
pulmonary [bpoc]
Hemodynamics [ortf]
treatment [ftcn]
Group [idcn]
Improvement [cnce]
minute [tmco]
Walking [dora]
Test [lbpr]
GR [aapp, rcpt]
M NOS [aapp, imft]
GR [aapp, rcpt]
32-P [elii, irda, phsu]
M NOS [aapp, imft]
Group [idcn]
Class [inpr]
trend [tmco]
Class [inpr]
GR [aapp, rcpt]
GR [aapp, rcpt]
4p [nusq]
Group [idcn]
Brain natriuretic peptide level [lbpr]
Plasma [bdsu]
Decrease [qlco]
GR [aapp, rcpt]
GR [aapp, rcpt]
pg/mL [qnco]
GR [aapp, rcpt]
pg/mL [qnco]
P NOS [aapp, imft]
Plasma [bdsu]
trend [tmco]
Decrease [qlco]
GR [aapp, rcpt]
GR [aapp, rcpt]
pg/mL [qnco]
GR [aapp, rcpt]
pg/mL [qnco]
Conclusions [idcn]
bosentan [orch, phsu]
effective [qlco]
therapy [ftcn]
Patients [podg]
Pulmonary arterial hypertension [dsyn]
Efficacy [qlco]
Effort [orgf]
Tolerance [fndg]
Independent [idcn]
baseline [bodm]
Venous [bpoc]
ET-1 [aapp, bacs]
Plasma [bdsu]
bosentan [orch, phsu]
therapy [ftcn]
elicit [qlco]
Patterns [spco]
Brain natriuretic peptide level [lbpr]
Plasma [bdsu]
Decrease [qlco]
Peptides [aapp]
Patients [podg]
Activation [acty]
Systemic [ftcn]
Endothelium [tisu]
System [ftcn]
IMPACT [gngm]
baseline [bodm]
Levels [qlco]
Long-Term Effects [phpr]
Worsening [qlco]
bosentan [orch, phsu]
therapy [ftcn]
Reserve [acty]
